Walleye Trading LLC

Position in ABVX — Abivax S.A.

CIK 1388391 NEW YORK, NY

Back to ABVX Full portfolio

Position in ABVX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$1,087,778

-$1,324,238 QoQ

Shares Held

9,769

-45.4% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Derivatives in ABVX

reported options exposure · as of Mar 31, 2026

CallValue

$1,870,680

CallShares

16,800

PutValue

$2,260,405

PutShares

20,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Walleye Trading LLC holds $17,472,598 across 36 Biotechnology names. ABVX ranks #4 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	10,390	$8,027,729
2	ALNY	Alnylam Pharmaceuticals, Inc.	5,756	$1,904,487
3	INSM	INSMED Inc	7,620	$1,246,022
4	ABVX	Abivax S.A. This page	9,769	$1,087,778
5	CRSP	CRISPR Therapeutics AG	15,086	$717,641
6	BNTX	BioNTech SE	6,431	$571,587
7	FOLD	AMICUS THERAPEUTICS, INC.	25,604	$370,233
8	MRNA	Moderna, Inc.	7,257	$368,655

All Filings in ABVX

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,870,680	16,800	+72.0%	Call	Sole	2026-05-11
2026-03-31	$1,087,778	9,769	-51.9%	Shares	Sole	2026-05-11
2026-03-31	$2,260,405	20,300	+13.5%	Put	Sole	2026-05-11
2025-12-31	$2,412,016	17,886	+138.5%	Shares	Sole	2026-02-13
2025-12-31	$1,011,412	7,500	-50.3%	Put	Sole	2026-02-13
2025-12-31	$2,036,310	15,100	—	Call	Sole	2026-02-13
No filing history on record for this holder in this stock.